Deutsche Biotech Innovativ AG banner
D

Deutsche Biotech Innovativ AG
F:DBI

Watchlist Manager
Deutsche Biotech Innovativ AG
F:DBI
Watchlist
Price: 5.05 EUR Market Closed
Market Cap: €4.8m

Profitability Summary

Deutsche Biotech Innovativ AG's profitability score is 35/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

35/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

35/100
Profitability
Score
35/100
Profitability
Score

Margins

Earnings Waterfall
Deutsche Biotech Innovativ AG

Margins Comparison
Deutsche Biotech Innovativ AG Competitors

Country Company Market Cap Operating
Margin
Net
Margin
DE
Deutsche Biotech Innovativ AG
XETRA:DBI
26m EUR
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
402.1B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
203.2B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
182B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.1B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
70.2B AUD
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
38.4B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Deutsche Biotech Innovativ AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
DE
Deutsche Biotech Innovativ AG
XETRA:DBI
26m EUR
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
402.1B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
203.2B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
182B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.1B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
70.2B AUD
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
38.4B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Deutsche Biotech Innovativ AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett